Climb Bio CLYM
NASDAQ CLYM
$11.07 -0.40 (-3.49%)
At close: Oct 1, 2026 · 4:00 PM EDT

Climb Bio (CLYM) Preferred Dividend Payments (2020 - 2021)

Updated

Climb Bio (CLYM) reported Preferred Dividend Payments of $4.55 million for FY2021, up 99.0% from $2.29 million in FY2020.

Analysis

Climb Bio (CLYM) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Preferred Dividend Payments came in at $2.29 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Climb Bio 873.49 Mn 873.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1.32 Mn
Jun 30, 2021 2.14 Mn
Mar 31, 2021 1.09 Mn
Dec 31, 2020 933,000.00
Sep 30, 2020 461,000.00
Jun 30, 2020 452,000.00
API Access

Climb Bio Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=CLYM&period=max&api_key=YOUR_API_KEY